Vimarsana
Biggest News Aggregation in the World

Monthly Index News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Monthly Index. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Monthly Index Today - Breaking & Trending Today

Iron Ore Price: China's Iron Ore Imports to Hit Record High - Vimarsana News

Iron Ore Price: China's Iron Ore Imports to Hit Record High

Thanks to India's low iron ore price, China is currently on a path to hit a new record for iron ore imports in 2024.

Freehold Royalties Announces First Quarter Results - Vimarsana News

Freehold Royalties Announces First Quarter Results

CALGARY, Alberta, May 06, 2024 -- Freehold Royalties Ltd. announces first quarter results for the period ended March 31, 2024. President’s Message $74 million in revenue;$54 million in funds...

India eyes to unlock MSME potential, pivots to digital public infra to catalyze growth - Vimarsana News

India eyes to unlock MSME potential, pivots to digital public infra to catalyze growth

The United Nation's First International Conference on Digital Public Infrastructure was held under India's leadership. Indian startup Jocata was praised at the UN conference for its first and only Monthly Index on MSME economic activity.

Some Singaporeans are heading to Malaysia for cheaper medicine. But is it safe? - Vimarsana News

Some Singaporeans are heading to Malaysia for cheaper medicine. But is it safe?

It's a given that many things you can find in Singapore can be found in Malaysia, albeit cheaper - but is there a risk in purchasing your medicine there? It seems that some Singaporeans have been regularly heading over to Johor Bahru for cheaper medication, according to an episode of Talking Point by CNA uploaded to YouTube on Tuesday (Jan...

Deanxit: The story of a drug that India has failed to ban - Vimarsana News

Deanxit: The story of a drug that India has failed to ban

The Centre banned the sale of Deanxit, a contested psychiatric drug approved without clinical data. But 10 years on, it continues to be sold by other companies.

Source: scroll.in